Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model

Brain metastases are common in patients with non-small-cell lung cancer (NSCLC). The efficacy of bevacizumab, an anti-vascular endothelial growth factor (VEGF) humanized antibody, has been demonstrated in patients with nonsquamous NSCLC. We established a transplantable NSCLC cell line (Nluc-H1915) t...

Descripción completa

Detalles Bibliográficos
Autores principales: Masuda, Chinami, Sugimoto, Masamichi, Wakita, Daiko, Monnai, Makoto, Ishimaru, Chisako, Nakamura, Ryo, Kinoshita, Mari, Yorozu, Keigo, Kurasawa, Mitsue, Kondoh, Osamu, Yamamoto, Kaname
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007905/
https://www.ncbi.nlm.nih.gov/pubmed/31768815
http://dx.doi.org/10.1007/s10585-019-10008-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007905/
https://www.ncbi.nlm.nih.gov/pubmed/31768815
http://dx.doi.org/10.1007/s10585-019-10008-z

Ejemplares similares